MedPath

Comparison between combined oral and topical 5-ASA versus topical 5-ASA on ulcerative proctitis.

Phase 2
Recruiting
Conditions
lcerative proctitis.
Ulcerative (chronic) proctitis
K51.2
Registration Number
IRCT20231029059892N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

All people who have been diagnosed with ulcerative proctitis through colonoscopy and histology during the years 1398-1402.
Patients over 15 years old

Exclusion Criteria

Patients with salicylate allergy
Active peptic disease
A proven coagulation problem
Pregnant and lactating women
Significant liver and kidney disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of disease activity. Timepoint: Start of study and 3 and 6 months later. Method of measurement: Simple Clinical Colitis Activity Index (SCCAI) And Disease Activity Index (DAI).;Response to treatment. Timepoint: Start of study and 6 months later. Method of measurement: Colonoscopy and Biopsy.;Laboratory criteria. Timepoint: Start of study and 3 and 6 months later. Method of measurement: Blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath